vs
Side-by-side financial comparison of F5, Inc. (FFIV) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $822.5M, roughly 1.8× F5, Inc.). F5, Inc. runs the higher net margin — 21.9% vs -13.6%, a 35.5% gap on every dollar of revenue. On growth, F5, Inc. posted the faster year-over-year revenue change (7.3% vs -5.3%). F5, Inc. produced more free cash flow last quarter ($149.5M vs $96.0M). Over the past eight quarters, F5, Inc.'s revenue compounded faster (9.9% CAGR vs -3.6%).
F5, Inc. is an American technology company specializing in application security, multi-cloud management, online fraud prevention, application delivery networking (ADN), application availability and performance, and network security, access, and authorization.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
FFIV vs OGN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $822.5M | $1.5B |
| Net Profit | $180.1M | $-205.0M |
| Gross Margin | 81.5% | 49.2% |
| Operating Margin | 26.0% | -9.8% |
| Net Margin | 21.9% | -13.6% |
| Revenue YoY | 7.3% | -5.3% |
| Net Profit YoY | 8.2% | -288.1% |
| EPS (diluted) | $3.10 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $822.5M | $1.5B | ||
| Q3 25 | $810.1M | $1.6B | ||
| Q2 25 | $780.4M | $1.6B | ||
| Q1 25 | $731.1M | $1.5B | ||
| Q4 24 | $766.5M | $1.6B | ||
| Q3 24 | $746.7M | $1.6B | ||
| Q2 24 | $695.5M | $1.6B | ||
| Q1 24 | $681.4M | $1.6B |
| Q4 25 | $180.1M | $-205.0M | ||
| Q3 25 | $190.5M | $160.0M | ||
| Q2 25 | $189.9M | $145.0M | ||
| Q1 25 | $145.5M | $87.0M | ||
| Q4 24 | $166.4M | $109.0M | ||
| Q3 24 | $165.3M | $359.0M | ||
| Q2 24 | $144.1M | $195.0M | ||
| Q1 24 | $119.0M | $201.0M |
| Q4 25 | 81.5% | 49.2% | ||
| Q3 25 | 82.2% | 53.5% | ||
| Q2 25 | 81.0% | 54.8% | ||
| Q1 25 | 80.7% | 55.6% | ||
| Q4 24 | 81.7% | 56.3% | ||
| Q3 24 | 80.8% | 58.3% | ||
| Q2 24 | 80.4% | 58.4% | ||
| Q1 24 | 79.3% | 59.0% |
| Q4 25 | 26.0% | -9.8% | ||
| Q3 25 | 25.4% | 15.2% | ||
| Q2 25 | 25.2% | 14.4% | ||
| Q1 25 | 21.7% | 6.7% | ||
| Q4 24 | 26.8% | 8.1% | ||
| Q3 24 | 25.6% | 13.1% | ||
| Q2 24 | 23.4% | 14.6% | ||
| Q1 24 | 20.5% | 14.5% |
| Q4 25 | 21.9% | -13.6% | ||
| Q3 25 | 23.5% | 10.0% | ||
| Q2 25 | 24.3% | 9.1% | ||
| Q1 25 | 19.9% | 5.8% | ||
| Q4 24 | 21.7% | 6.8% | ||
| Q3 24 | 22.1% | 22.7% | ||
| Q2 24 | 20.7% | 12.1% | ||
| Q1 24 | 17.5% | 12.4% |
| Q4 25 | $3.10 | $-0.78 | ||
| Q3 25 | $3.25 | $0.61 | ||
| Q2 25 | $3.25 | $0.56 | ||
| Q1 25 | $2.48 | $0.33 | ||
| Q4 24 | $2.82 | $0.42 | ||
| Q3 24 | $2.79 | $1.38 | ||
| Q2 24 | $2.44 | $0.75 | ||
| Q1 24 | $2.00 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | $574.0M |
| Total DebtLower is stronger | — | $8.6B |
| Stockholders' EquityBook value | $3.5B | $752.0M |
| Total Assets | $6.3B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.2B | $574.0M | ||
| Q3 25 | $1.3B | $672.0M | ||
| Q2 25 | $1.4B | $599.0M | ||
| Q1 25 | $1.3B | $547.0M | ||
| Q4 24 | $1.2B | $675.0M | ||
| Q3 24 | $1.1B | $763.0M | ||
| Q2 24 | $935.6M | $704.0M | ||
| Q1 24 | $903.5M | $575.0M |
| Q4 25 | — | $8.6B | ||
| Q3 25 | — | $8.8B | ||
| Q2 25 | — | $8.9B | ||
| Q1 25 | — | $9.0B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $3.5B | $752.0M | ||
| Q3 25 | $3.6B | $906.0M | ||
| Q2 25 | $3.5B | $733.0M | ||
| Q1 25 | $3.3B | $542.0M | ||
| Q4 24 | $3.2B | $472.0M | ||
| Q3 24 | $3.1B | $493.0M | ||
| Q2 24 | $3.0B | $144.0M | ||
| Q1 24 | $2.9B | $48.0M |
| Q4 25 | $6.3B | $12.9B | ||
| Q3 25 | $6.3B | $13.6B | ||
| Q2 25 | $6.1B | $13.5B | ||
| Q1 25 | $5.9B | $13.2B | ||
| Q4 24 | $5.9B | $13.1B | ||
| Q3 24 | $5.6B | $12.8B | ||
| Q2 24 | $5.4B | $12.2B | ||
| Q1 24 | $5.4B | $11.9B |
| Q4 25 | — | 11.49× | ||
| Q3 25 | — | 9.74× | ||
| Q2 25 | — | 12.14× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | — | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $159.2M | $141.0M |
| Free Cash FlowOCF − Capex | $149.5M | $96.0M |
| FCF MarginFCF / Revenue | 18.2% | 6.4% |
| Capex IntensityCapex / Revenue | 1.2% | 3.0% |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $861.2M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.2M | $141.0M | ||
| Q3 25 | $208.1M | $264.0M | ||
| Q2 25 | $282.2M | $220.0M | ||
| Q1 25 | $256.6M | $75.0M | ||
| Q4 24 | $202.8M | $390.0M | ||
| Q3 24 | $246.5M | $141.0M | ||
| Q2 24 | $159.0M | $332.0M | ||
| Q1 24 | $221.6M | $76.0M |
| Q4 25 | $149.5M | $96.0M | ||
| Q3 25 | $191.9M | $218.0M | ||
| Q2 25 | $273.7M | $181.0M | ||
| Q1 25 | $246.1M | $43.0M | ||
| Q4 24 | $194.7M | $335.0M | ||
| Q3 24 | $240.4M | $99.0M | ||
| Q2 24 | $153.1M | $300.0M | ||
| Q1 24 | $212.2M | $30.0M |
| Q4 25 | 18.2% | 6.4% | ||
| Q3 25 | 23.7% | 13.6% | ||
| Q2 25 | 35.1% | 11.4% | ||
| Q1 25 | 33.7% | 2.8% | ||
| Q4 24 | 25.4% | 21.0% | ||
| Q3 24 | 32.2% | 6.3% | ||
| Q2 24 | 22.0% | 18.7% | ||
| Q1 24 | 31.1% | 1.8% |
| Q4 25 | 1.2% | 3.0% | ||
| Q3 25 | 2.0% | 2.9% | ||
| Q2 25 | 1.1% | 2.4% | ||
| Q1 25 | 1.4% | 2.1% | ||
| Q4 24 | 1.1% | 3.5% | ||
| Q3 24 | 0.8% | 2.7% | ||
| Q2 24 | 0.8% | 2.0% | ||
| Q1 24 | 1.4% | 2.8% |
| Q4 25 | 0.88× | — | ||
| Q3 25 | 1.09× | 1.65× | ||
| Q2 25 | 1.49× | 1.52× | ||
| Q1 25 | 1.76× | 0.86× | ||
| Q4 24 | 1.22× | 3.58× | ||
| Q3 24 | 1.49× | 0.39× | ||
| Q2 24 | 1.10× | 1.70× | ||
| Q1 24 | 1.86× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FFIV
| Services | $412.2M | 50% |
| Products | $410.3M | 50% |
OGN
Segment breakdown not available.
